Advisory Services Network, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Advisory Services Network, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$98.85 - $138.91 $7,512 - $10,557	-76 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$65.78 - $105.02 $4,999 - $7,981	76 New	76 $7,000
Q1 2021 May 24, 2021	SELL	$64.07 - $91.75 $3,075 - $4,404	-48 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$59.04 - $77.95 $2,833 - $3,741	48 New	48 $3,000
Q2 2020 Aug 10, 2020	SELL	$29.01 - $74.23 $1,392 - $3,563	-48 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $1,320 - $2,749	48 New	48 $2,000
Q2 2019 Aug 01, 2019	SELL	$39.79 - $67.01 $7,958 - $13,402	-200 Closed	0 $0
Q1 2019 May 20, 2019	BUY	$34.52 - $53.29 $6,904 - $10,658	200 New	200 $10,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.27B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.